0001104659-26-024231.txt : 20260305 0001104659-26-024231.hdr.sgml : 20260305 20260305180625 ACCESSION NUMBER: 0001104659-26-024231 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20260217 FILED AS OF DATE: 20260305 DATE AS OF CHANGE: 20260305 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sy Jennifer CENTRAL INDEX KEY: 0002023998 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40021 FILM NUMBER: 26727773 MAIL ADDRESS: STREET 1: C/O AEON BIOPHARMA, INC. STREET 2: 5 PARK PLAZA, SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AEON Biopharma, Inc. CENTRAL INDEX KEY: 0001837607 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 853940478 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: (949) 354-6499 MAIL ADDRESS: STREET 1: 5 PARK PLAZA STREET 2: SUITE 1750 CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: Priveterra Acquisition Corp. DATE OF NAME CHANGE: 20201222 4 1 tm268148-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2026-02-17 0 0001837607 AEON Biopharma, Inc. AEON 0002023998 Sy Jennifer C/O AEON BIOPHARMA, INC. 5 PARK PLAZA, SUITE 1750 IRVINE CA 92614 0 1 0 0 PRINCIPAL ACCOUNTING OFFICER 0 Class A Common Stock 2026-02-17 4 A 0 575000 0 A 575251 D Class A Common Stock 2026-03-04 4 A 0 925925 0 A 1501176 D Represents an award of restricted stock units granted on February 17, 2026 (the "Grant Date"), which vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date. Represents outstanding cash-settled restricted stock units granted on May 21, 2025 (the "Grant Date") that were modified on March 4, 2026 to be settled in stock instead of cash upon vesting. The restricted stock units continue to vest in substantially equal installments on each of the first, second, third and fourth anniversary of the Grant Date, subject to continued service through the applicable vesting date. The restricted stock units were originally reported in Table II on a Form 4 filed on May 23, 2025. /s/ Alexander Wilson, as Attorney-in-Fact, for Jennifer Sy 2026-03-05